Medical Marijuana's Subsidiary Kannaway Reveals Record Revenue Month For South Africa And Japan Divisions

Medical Marijuana, Inc. MJNA confirmed Tuesday that its subsidiary Kannaway achieved its largest revenue month in the company’s history in its Japan and South Africa divisions in January 2022.

“Being able to achieve four best revenue months in a row in the Japan market has been both a great way to end 2021 and an inspiring way to start 2022,” Medical Marijuana, Inc. CEO Blake Schroeder stated. “Now that we’ve reached this milestone in South Africa as well, we anticipate that both regions will be major market areas for us this year and beyond.”

According to Business Insider Africa, Africa’s cannabis industry is projected to grow beyond a $7 billion valuation by 2023. Reach and Markets highlights that the Asia-Pacific market is also expected to grow exponentially with a CAGR of 28.6% from 2020 to 2027.

Price Action

Medical Marijuana shares traded 0.60% higher at $0.0167 per share at the time of writing Tuesday morning.

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsPenny StocksMarkets
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!